Cello Group plc Issue of Equity (9606N)
September 13 2013 - 7:07AM
UK Regulatory
TIDMCLL
RNS Number : 9606N
Cello Group plc
13 September 2013
Cello Group plc (the "Group" or the "Company")
Additional listing / TVR
The Company announces that on 13 September 2013 it resolved to
issue 196,188 new ordinary shares of 10p each to vendors of a
business previously acquired by the Group. These shares are to be
issued pursuant to the share purchase agreement in relation to Mash
Healthcare Group Limited
Application has been made for these shares to be admitted to
trading on AIM and admission is expected to occur on 19 September
2013. The Company's issued share capital, following the admission
of the 196,188 new shares, will be 83,072,552 ordinary shares of 10
pence each ("Ordinary Shares"), all with voting rights. The Company
holds 381,000 Ordinary Shares in treasury at the date of this
announcement. The total number of current voting rights in the
Company will therefore be 82,691,552 shares.
The above figure (82,691,552 Ordinary Shares) may be used by
shareholders as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the Company under the FCA's
Disclosure and Transparency Rules.
13 September 2013
For further Information please contact:
Cello Group plc
Mark Scott, Chief Executive 020 7812 8460
Mark Bentley, Group Finance Director
Cenkos Securities plc
Bobbie Hilliam 020 7397 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOELJMBTMBMBBIJ
Cello Health (LSE:CLL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cello Health (LSE:CLL)
Historical Stock Chart
From Jul 2023 to Jul 2024